Anticancer quinones induce pRb-preventable G2/M cell cycle arrest and apoptosis

Free Radical Biology and Medicine

Volumn 24, Issue 5, 1998, Pages 848-854

  Qiu, Xiao Bo ^a   Schönthal, Axel H ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Free radical; p21; pRb; Quinone; Reactive oxygen species

Indexed keywords

3,6 DIAZIRIDINYL 1,4 BENZOQUINONE; ANTINEOPLASTIC AGENT; PROTEIN P21; PROTEIN P53; QUINONE DERIVATIVE; RETINOBLASTOMA PROTEIN; RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; COLON CARCINOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AZIRIDINES; BENZOQUINONES; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; G2 PHASE; HUMANS; HYDROGEN PEROXIDE; MITOSIS; OSTEOSARCOMA; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0032521127     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00368-7     Document Type: Article

References (20)

1. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
2. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
3. Haas-Kogan D. A., Kogan S. C., Levi D., Dazin P., T'Ang A., Fung Y. T., Israel M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
4. Haupt Y., Rowan S., Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRb. Oncogene. 10:1995;1563-1571.
5. Qiu X.-B., Forman H. J., Schönthal A. H., Cadenas E. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells. J. Biol. Chem. 271:1996;31915-31921.
6. Fung Y.-K. T., T'Ang A., Murphree L., Zhang F., Qiu W., Wang S., Shi X., Lee L., Driscoll B., Wu K. The Rb gene suppresses the growth of normal cells. Oncogene. 8:1993;2659-2672.
7. Ausubel F. M., Brent B., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current protocols in molecular biology. 1993;John Wiley & Sons, Inc. New York.
8. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
9. Harper J. W., Elledge S. J., Keyomarsi K., Dynlacht B., Tsai L. H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., Fox M. P., Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
10. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
11. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
12. Kerr J. F. R., Winterford C. M., Harmon B. V. Apoptosis Its significance in cancer and cancer therapy . Cancer. 73:1994;2013-2036.
13. Field S. J., Tsai F.-Y., Kuo F., Zubiaga A. M., William G. K., Livingston D. M., Orkin S. H., Greenberg M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 85:1996;549-561.
14. Sellers W., Rodgers J., Kaelin W. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:1995;11544-11548.
15. Johnson T. M., Yu Z.-X., Ferrans V. J., Lowenstein R. A., Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;11848-11852.
16. Lowe S. W., Bodis S., McClatchey A., Remington L., Ruley H. E., Fisher D. E., Housman D. E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
17. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parson R., Trent J. M., Lind D., Mercer E., Kinzler K. W., Volgelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
18. Katayose D., Wersto R., Cowan K. H., Seth P. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ. 6:1995;1207-1212.
19. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:1996;359-361.
20. 1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res. 55:1995;5493-5498.